Testicular cancer survivors at higher risk of secondaries decades later
It might be explained by genetic susceptibility, the researchers said
Men treated with cisplatin-based chemotherapy for testicular cancer are at substantially increased risk of developing a second cancer decades later, according to new findings.
And chemotherapy in combination with radiotherapy doubles their risk of later developing malignancies of the prostate, lung, bladder or colon.
